Drawing for TRIALXCH

USPTO serial 88955869

TRIALXCH

Reviewed by CopyMark Law Group

Reg. 6325549Status 700Renewal
Filing date
Status date
Registration date
Apr 20, 2021
Examiner
O'BRIEN, JENNIFER LYNN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TRIALXCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Price

Andrew D. Price VENABLE LLPP.O. BOX 34385WASHINGTON, DC 20043-9998UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing temporary use of online, non-downloadable, internet-based software for use in clinical trials, namely, for providing information management and analytics services for identifying matching patients for participation in clinical trials, study design and associated analysis, using aggregated clinical data on patients from hospitals, and aggregating information on clinical trials inclusion/exclusion criteria from the public domain; Software as a Service (SaaS) featuring software for providing digital solutions in the nature of providing information management and analytics services for identifying matching patients for participation in clinical trials, study design and associated analysis, using aggregated clinical data on patients from hospitals, and aggregating information on clinical trials inclusion/exclusion criteria from the public domain, system optimization, performance management, and system support, all in the field of clinical trials; Providing temporary use of a web-based software application for identifying and matching patients for participation in clinical trials; Software as a service (SaaS) services featuring software for identifying and matching patients for participation in clinical trials; Providing temporary use of online, non-downloadable, internet-based software for use in aggregating clinical data from patients, hospitals, and medical professionals for use in clinical trials; Software as a Service (SaaS) featuring software for aggregating clinical data from patients, hospitals, and medical professionals for use in clinical trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 20, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 2, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 2, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 13, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 31, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 29, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 29, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 21, 2020ALIEASSIGNED TO LIE—
Dec 11, 2020ALIEASSIGNED TO LIE—
Sep 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 15, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 15, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 11, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 11, 2020DOCKASSIGNED TO EXAMINER—
Jul 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 12, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance